Tag: All about ICSR processing
Within this tag, you will discover a complete repository of information pertaining to ICSR (Individual Case Safety Report) cases, presented systematically from top to bottom at each level.
-
🪪 Listedness and Labelling: Explained
This blog covers: Introduction This blog focuses on the processes involved in conducting causality assessments. You will learn about the distinctions between two terms in this context: listedness and labelling, along with their interconnections. Listedness Listedness refers to the recorded terms derived from pre-clinical study data. In which encompass monitored and documented events related to…
-
🗓️ Picking Receipt Dates For Various Scenarios
In this article, you’ll learn how to picking receipt dates during case processing in various scenarios—a commonly confusing aspect. We will explore the complexities involved and provide clarity on this often intricate topic.
-
🥨 E2B and E2B(R2) and E2B(R3): The Variations
Welcome to our informative blog. Here you can learn about the difference between E2b (R2) and E2b (R3), Building upon our previous discussion about E2B, we now delve deeper into the evolution of the E2B standard.
-
The Significance of Receipt Dates in Pharmacovigilance
In this blog, where you can learn the significance of receipt dates in ICSR (Individual Case Safety Report) case processing and their impact on submissions. Join us as we explore the context of case processing in related with receipt dates.
-
🔗 Linking ICSR Cases: A Valid Criteria
In this comprehensive blog, we explore what case linking means in the context of ICSR cases and also explain the criteria for linking cases.
-
What is Case Receipt in Pharmacovigilance?
Welcome to the next installment of our ICSR category series in our blog, where we delve into the definitions of various receipt dates in ICSR case processing.
-
🌀 Exploring the Origins: Sources of ICSR reports
In this article, we delve into the scope and purpose of ICSR reports, shedding light on the reporters involved and the sources they draw upon. If you’re interested in gaining a deeper understanding of pharmacovigilance, this article is sure to provide valuable insights.
-
Understanding SUSAR cases: How it differs from other serious cases?
Welcome to our enlightening blog, where we explore the distinction between SUSAR (Suspected Unexpected Serious Adverse Reaction) cases and other serious cases, highlighting their unique characteristics and significance.
